GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Verseon Corp (GREY:VERS) » Definitions » Change In Payables And Accrued Expense

Verseon (Verseon) Change In Payables And Accrued Expense : $0.00 Mil (TTM As of Jun. 2019)


View and export this data going back to 2016. Start your Free Trial

What is Verseon Change In Payables And Accrued Expense?

Verseon's Change In Payables And Accrued Expense for the quarter that ended in Jun. 2019 was $0.00 Mil. It means Verseon's Accounts Payable & Accrued Expense stayed the same from Dec. 2018 to Jun. 2019 .

Verseon's Change In Payables And Accrued Expense for the fiscal year that ended in Dec. 2018 was $0.00 Mil. It means Verseon's Accounts Payable & Accrued Expense stayed the same from Dec. 2017 to Dec. 2018 .


Verseon Change In Payables And Accrued Expense Historical Data

The historical data trend for Verseon's Change In Payables And Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Verseon Change In Payables And Accrued Expense Chart

Verseon Annual Data
Trend Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18
Change In Payables And Accrued Expense
Get a 7-Day Free Trial - - - - -

Verseon Semi-Annual Data
Dec11 Dec12 Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19
Change In Payables And Accrued Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Verseon Change In Payables And Accrued Expense Calculation

Change In Payables And Accrued Expense is the increase or decrease between periods of the Accounts Payable & Accrued Expense. Accrued expenses represent expenses incurred at the end of the reporting period but not yet paid; also called accrued liabilities. The accrued liability is shown under Liabilities section in the balance sheet.

Change In Payables And Accrued Expense for the trailing twelve months (TTM) ended in Jun. 2019 adds up the semi-annually data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Verseon Change In Payables And Accrued Expense Related Terms

Thank you for viewing the detailed overview of Verseon's Change In Payables And Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


Verseon (Verseon) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Verseon Corp (GREY:VERS) » Definitions » Change In Payables And Accrued Expense
Traded in Other Exchanges
N/A
Address
47071 Bayside Parkway, Fremont, CA, USA, 94538
Verseon Corp is a part of the healthcare sector in the United States. It is a technology-based pharmaceutical company with a computer-driven drug discovery platform. The company designs novel drug candidates that are unlikely to be found using conventional methods. It is also engaged in drug discovery programs such as the diabetic macular edema product candidates, which treat the diseases by controlled disruption of the kallikrein kinin cascade.

Verseon (Verseon) Headlines